References

  1. Cole PJ. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl. 1986; 147: 6-15. PubMed | Google Scholar

  2. Journeau S, Kerjouan M, Desrues B, Delaval P. Dilatation des bronches. In: Lemarié E. La pneumologie fondée sur les preuves, Paris, Margaux Orange, 2013; pp. 195-214. Google Scholar

  3. Barker AF, Bardana EJ Jr. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis. 1988 Apr;137(4):969-78. PubMed | Google Scholar

  4. Minov J, Karadzinska-Bislimovska J, Vasilevska K, Stoleski S, Mijakoski D. Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity : The FACED Score vs the Bronchiectasis Severity Index. Open Respir Med J. 2015 Mar 31; 9: 46-51. PubMed | Google Scholar

  5. Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007 Nov; 132(5): 1565-72. PubMed | Google Scholar

  6. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA et al. An invetigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000 Oct; 162(4 Pt 1): 1277-84. PubMed | Google Scholar

  7. Pasteur MC, Bilton D, Hill AT. British Thoracic Society Guideline for non-CF bronchiectasis. Thorax. 2010 Jul;65 Suppl 1: i1-58. PubMed | Google Scholar

  8. Orriols R, Núñez V, Hemando R, Drobnic E, Moreiras M. Life-threatning hemoptysis: study of 154 patients. Med Clin (Barc). 2012 Sep 8; 139(6): 255-60. PubMed | Google Scholar

  9. Remy J, Marache P. Les bronchectasies. In Bismuth V BM, Remy J: Traité de radiodiagnostic. 2 Masson: 1979; 349-67. Google Scholar

  10. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthris: Clinicat, functional, and HRCT findings. Am J Respir Crit Care Med. 1998 May; 157(5 Pt 1): 1658-65. PubMed | Google Scholar

  11. Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British Thorac Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011 Jun; 20(2): 135-40. PubMed | Google Scholar

  12. Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997 Aug; 10(8): 1754-60. PubMed | Google Scholar

  13. Hare KM, Brinks MJ, Grimwood K, Chang AB, Leach AJ, Smith-Vaughan H. Culture and PCR detection of Haemophilus influenzae and Haemophilus haemolyticus in Australien indigenous children with bronchiectasis. J Clin Microbiol. 2012; 50:2444-5. PubMed | Google Scholar

  14. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011; 184(8): 957-63. PubMed | Google Scholar

  15. Wilson CB, Jones PW, O'leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997 Aug; 10(8): 1754-60. PubMed | Google Scholar

  16. Davies G, Wells AU, Doffman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary fonction in patients with bronchiectasis. Eur Respir J. 2006 Nov; 28(5): 974-9. PubMed | Google Scholar

  17. Miszkiel KA, Wells AU, Rubens MB, Cole PJ, Hansell DM. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax. 1997 Mar; 52(3): 260-4. PubMed | Google Scholar

  18. Evans SA, Tuner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiactasis: The influence of pseudomonas aeruginosa. Eur Respir J. 1996 Aug; 9(8): 1601-4. PubMed | Google Scholar

  19. Chan CH, Ho AK, Chan RC, Cheung H, Cheng AF. Mycobacteria as a cause of infective exacerbation in bronchectasis. Postgrad Med J. 1992 Nov; 68(805): 896-9. PubMed | Google Scholar